Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Graham Lohrmann"'
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 65:695-700
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc7f51d6d87dd2e4581b97ed53df0c92
https://doi.org/10.1007/s10840-022-01326-6
https://doi.org/10.1007/s10840-022-01326-6
Autor:
Albert Y. Liu, Jessica Charron, Dana Fugaro, Scott Spoolstra, Rachel Kaplan, Graham Lohrmann, Xu Gao, Hawkins Gay, Rod Passman, Susan Kim, Albert C. Lin, Alexandru Chicos, Rishi Arora, Kaustubha Patil, Anna Pfenniger, Bradley P. Knight, Nishant Verma
Introduction Oral sotalol initiation requires a multiple-day, inpatient admission to monitor for QT prolongation during loading. A one-day intravenous (IV) sotalol loading protocol was approved by the FDA in March 2020, but limited data on clinical u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff16744de782f0936dece8efe1b364e
https://doi.org/10.22541/au.166373868.87329315/v1
https://doi.org/10.22541/au.166373868.87329315/v1
Autor:
Graham Lohrmann, Rod S. Passman
Publikováno v:
Journal of Cardiovascular Electrophysiology. 32:2808-2812
Monitoring following catheter or surgical ablation for atrial fibrillation (AF) is an essential tool used to assess outcomes for research purposes and help guide clinical decision making. The most commonly used methods to monitor for post-interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::394243ec5e4a754c0623d484af4c725f
https://doi.org/10.1111/jce.14847
https://doi.org/10.1111/jce.14847
Autor:
John L. Berk, Graham Lohrmann, Omar K. Siddiqi, Deepa M. Gopal, Jennifer Hellawell, Mathew S. Maurer, Lawreen H. Connors, Roberta Mussinelli, Nirupama Vellanki, Alexandra Pipilas, Jonathan C. Fox, Frederick L. Ruberg
Publikováno v:
Journal of Cardiac Failure. 26:753-759
Background Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an underappreciated cause of heart failure that results from misfolded TTR (prealbumin) protein. Diflunisal is an approved non-steroidal anti-inflammatory drug that stabilizes TTR, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53563de8346c4a26677c412140ebf48
https://doi.org/10.1016/j.cardfail.2019.11.024
https://doi.org/10.1016/j.cardfail.2019.11.024
Autor:
Omar K. Siddiqi, Yuliya Y. Mints, John L. Berk, Lawreen Connors, Gheorghe Doros, Deepa M. Gopal, Shivangi Kataria, Graham Lohrmann, Alexandra R. Pipilas, Frederick L. Ruberg
Publikováno v:
Amyloid
Diflunisal is a non-steroidal anti-inflammatory drug that stabilises transthyretin (TTR) and reduces neurologic deterioration in patients with polyneuropathy caused by hereditary transthyretin amyloidosis (ATTRv). We conducted a retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ae0f2bb7ff9afb5dffa94d939ef5a5
Autor:
Albert Y Liu, Graham Lohrmann, Paul D Ziegler, Joao V Monteiro, Nathan V Varberg, Rod S Passman
Publikováno v:
Circulation. 144
Introduction: There are few readily available and effective risk stratification tools for successful catheter ablation (CA) of atrial fibrillation (AF). CHA 2 DS 2 VASc score is a marker for vascular disease and has been shown to be mildly predictive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a98e0d4b110975bd62ffae7c2999d2f
https://doi.org/10.1161/circ.144.suppl_1.11519
https://doi.org/10.1161/circ.144.suppl_1.11519
Publikováno v:
Journal of cardiovascular electrophysiologyREFERENCES. 31(12)
Introduction Ablation for atrial fibrillation (AF) has emerged as an effective method of rhythm control. This exploratory analysis aimed to determine how various measures of recurrence would influence the definition of treatment success. Methods Usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef479a2eca5b823593cb049c7e24d385
https://pubmed.ncbi.nlm.nih.gov/33079437
https://pubmed.ncbi.nlm.nih.gov/33079437
Autor:
Roberta Mussinelli, Graham Lohrmann, Stefano Perlini, Vaishali Sanchorawala, Frederick L Ruberg, Deepa M Gopal
Publikováno v:
Circulation. 136
Introduction: Cardioembolic events are common in cardiac amyloidosis (CA) in the absence of atrial fibrillation. In sinus rhythm (SR), marked reduction in the atrial component of left ventricular filling confers a physiology of atrial electromechanic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e4ea7e5bd62d69205fef0affa7f9480
https://doi.org/10.1161/circ.136.suppl_1.21169
https://doi.org/10.1161/circ.136.suppl_1.21169
Autor:
Dina Brauneis, Frederick L. Ruberg, Deepa M. Gopal, Karen Quillen, Vaishali Sanchorawala, Omar K. Siddiqi, Monica Arun, Shayna Sarosiek, Graham Lohrmann
Publikováno v:
Journal of the American College of Cardiology. 71:A1517
Incident atrial fibrillation (AF) resulting in hypotension and ICU care is a significant occurrence complicating stem cell transplantation (SCT) for AL amyloidosis. We have reported that while a history of AF predicted post-SCT AF, echocardiographic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a294671a71ee0c851e061a4d377badbc
https://doi.org/10.1016/s0735-1097(18)32058-8
https://doi.org/10.1016/s0735-1097(18)32058-8